Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Warts × Clear all

Phase

Status

Completed 21 Unknown 2 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 8 Melanoma 6 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Rectal Neoplasms 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Breast Neoplasms 2 Warts 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Adenocarcinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrent Head and Neck Carcinoma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Phase 2 Study 1 Peritoneal Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01796795 2023-09-14

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

G&E Herbal Biotechnology Co., LTD

Phase 2 Suspended

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡